Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NUL
  • 52 Week Low: 3.00p
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 0
  • Beta: 0.00

Omega Diagnostics receives deferred £4m from CD4 sale

By Josh White

Date: Friday 25 Nov 2022

LONDON (ShareCast) - (Sharecast News) - Omega Diagnostics confirmed the receipt of deferred consideration from the sale of the CD4 business on Friday.
The AIM-traded medical diagnostics company said it had now received the £4m of deferred consideration.

"Accordingly, as of close-of-business on 24 November, Omega held cash balances of £6.5m," the board said in its short statement.

At 1116 GMT, shares in Omega Diagnostics Group were up 10.83% at 3.99p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NUL
52 Week Low 3.00p
Volume 0
Shares Issued 237.95m
Beta 0.00

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.47% below the market average6.47% below the market average6.47% below the market average6.47% below the market average6.47% below the market average
39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average39.39% above the sector average
Price Trend
50.42% above the market average50.42% above the market average50.42% above the market average50.42% above the market average50.42% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Income Not Available
Growth
28.50% above the market average28.50% above the market average28.50% above the market average28.50% above the market average28.50% above the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

CNSL Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CNSL Key Personnel

CFO Ajay Patel

Top of Page